Argentina Faces Immunization Gap as Meningitis Vaccination Coverage Declines Among Adolescents

Argentina's meningitis vaccination coverage drops significantly from nearly 90 percent in infants to 57 percent for adolescents, creating immunity gaps that weaken population protection against the disease. Public health data shows that serogroup B, responsible for most invasive cases in minors, is not included in the national immunization schedule despite free vaccine availability for other strains. The World Health Organization has documented substantial meningitis transmission risks in crowded conditions, with severe epidemic waves previously affecting countries across the African meningitis belt.

Argentina's immunization infrastructure demonstrates effectiveness in reaching infants, yet faces progressive challenges maintaining protection as children mature into adolescence. The documented decline from near-universal infant coverage to approximately 57 percent adolescent vaccination suggests systemic barriers in recall mechanisms, parental awareness, or healthcare delivery. This pattern mirrors broader vaccination challenges where age-specific outreach becomes increasingly difficult despite policy availability.

The epidemiological gap presents a particular vulnerability: serogroup B meningococcus causes the majority of severe childhood cases, yet remains absent from Argentina's free vaccine schedule. While other bacterial strains receive public health protection through conjugate vaccines, families seeking comprehensive coverage must navigate private markets and associated costs, creating disparities in access to preventive measures.